🇨🇦 Angiotensin-Converting Enzyme Inhibitors in Canada

Angiotensin-Converting Enzyme Inhibitors (Angiotensin-Converting Enzyme Inhibitors) regulatory status in Canada.

Marketing authorisation

Angiotensin-Converting Enzyme Inhibitors in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Angiotensin-Converting Enzyme Inhibitors approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Angiotensin-Converting Enzyme Inhibitors in Canada?

Boehringer Ingelheim is the originator. The local marketing authorisation holder may differ — check the official source linked above.